Page last updated: 2024-11-07

tetrahydrocortisol and Ocular Hypertension

tetrahydrocortisol has been researched along with Ocular Hypertension in 1 studies

Ocular Hypertension: A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.

Research Excerpts

ExcerptRelevanceReference
"3 alpha, 5 beta-tetrahydrocortisol, previously considered an inactive metabolite of cortisol, was found to lower significantly the intraocular pressure (IOP) of rabbits made ocular hypertensive with dexamethasone alone or with threshold levels of dexamethasone plus 5 beta-dihydrocortisol."3.67Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol. ( Gordon, GG; l'Hommedieu, D; Southren, AL; Weinstein, BI, 1987)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Southren, AL1
l'Hommedieu, D1
Gordon, GG1
Weinstein, BI1

Other Studies

1 other study available for tetrahydrocortisol and Ocular Hypertension

ArticleYear
Intraocular hypotensive effect of a topically applied cortisol metabolite: 3 alpha, 5 beta-tetrahydrocortisol.
    Investigative ophthalmology & visual science, 1987, Volume: 28, Issue:5

    Topics: Animals; Dexamethasone; Glaucoma, Open-Angle; Humans; Hydrocortisone; Intraocular Pressure; Ocular H

1987